Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

Modern weight loss treatments have transformed how we approach obesity management, but they come with concerning side effects. The growing use of glucagon-like peptide-1 medications has ...

He has been critical of the boom in weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro. Kush Desai, a White House spokesman, said the order follows concerns about doctors ...

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where many cannot afford the drugs. A video monitoring system inside a pharmacy ...